000 | 01812 a2200517 4500 | ||
---|---|---|---|
005 | 20250516020215.0 | ||
264 | 0 | _c20110526 | |
008 | 201105s 0 0 eng d | ||
022 | _a1528-0012 | ||
024 | 7 |
_a10.1053/j.gastro.2010.12.038 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHitomi, Yuki | |
245 | 0 | 0 |
_aInosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. _h[electronic resource] |
260 |
_bGastroenterology _cApr 2011 |
||
300 |
_a1314-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xbiosynthesis |
650 | 0 | 4 |
_aAdenylosuccinate Synthase _xmetabolism |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnemia _xchemically induced |
650 | 0 | 4 |
_aAntiviral Agents _xtoxicity |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aErythrocytes _xdrug effects |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aGuanosine Triphosphate _xmetabolism |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInosine Triphosphate _xpharmacology |
650 | 0 | 4 |
_aPyrophosphatases _xgenetics |
650 | 0 | 4 |
_aRibavirin _xtoxicity |
650 | 0 | 4 | _aYoung Adult |
650 | 0 | 4 | _aInosine Triphosphatase |
700 | 1 | _aCirulli, Elizabeth T | |
700 | 1 | _aFellay, Jacques | |
700 | 1 | _aMcHutchison, John G | |
700 | 1 | _aThompson, Alexander J | |
700 | 1 | _aGumbs, Curtis E | |
700 | 1 | _aShianna, Kevin V | |
700 | 1 | _aUrban, Thomas J | |
700 | 1 | _aGoldstein, David B | |
773 | 0 |
_tGastroenterology _gvol. 140 _gno. 4 _gp. 1314-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2010.12.038 _zAvailable from publisher's website |
999 |
_c20485794 _d20485794 |